Analytical Framework for Examining the Value of Antibacterial Products. 4.4 Social EPV Model Parameters and Assumptions


The framework we used to assess social benefits for a new ABOM vaccine is the same as that used for antibacterial drugs and described earlier in this report. We use the same values for the real annual social discount rate, VSL, and VSLY as in the antibacterial drugs model.  Table 20 presents the point estimates for the social EPV model parameters and assumptions.  The following sections discuss the basis for these estimates in further detail.

View full report


"rpt_antibacterials.pdf" (pdf, 1.43Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®